In this episode, psychiatrist Dr. Matt Bernstein (founder of ACCORD) explains why metabolic therapies—ketogenic nutrition, circadian alignment, exercise, and mind-body work—often improve energy, mood, sleep, focus, and even psychosis, while enabling safer deprescribing. We dig into why standard care so often fails to restore function; what ketogenic diets can do in severe illness; why incentives from Big Food, Big Pharma, and insurers sideline foundational lifestyle care; and what families can start doing right now—because real change is likely to be grassroots.

In this interview, Dr. Jeffrey Wiegers (BioReset Medical) explains what MUSE stem cells are, how they differ from traditional mesenchymal stem cells, and whether they might help after neurological injuries—concussion/TBI, stroke, chemo neuropathy, or protracted withdrawal (including PSSD). We also cover safety, side effects, why sourcing and good manufacturing practice matter, and new state-level pathways in the U.S.

https://www.bioresetmedical.com/

John and Dee Foster were severely harmed by benzodiazepines—yet instead of staying silent, they spent years fighting for change. Their persistence paid off: the new ASAM benzodiazepine deprescribing guidelines now formally acknowledge physical dependence, protracted withdrawal, the need for slow, patient-led tapers that can take months to years, the importance of shared decision-making, and the role of peer and non-drug supports.

John and Dee share what they won for patients, and why these guidelines could mark a turning point in holding the medical system accountable.